Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEDAPT-TICA: Ticagrelor De-Escalation in Stroke/TIA
NCT06653348Phase 3Recruiting
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Mazandaran University of Medical Sciences. Started Apr 2024; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
ischemic strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT06653348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653348.